Metropolitan Life Insurance Company (MetLife)’s Vicarious Surgical RBOT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-115	Closed	-$6.32K	–	2437
2023 Q2	$6.32K	Hold	115	–	–	﹤0.01%	2443
2023 Q1	$7.84K	Sell	115 -18	-14%	-$1.4K	﹤0.01%	2228
2022 Q4	$8.06K	Buy	133 +4	+3%	+$372	﹤0.01%	2326
2022 Q3	$12.9K	Hold	129	–	–	﹤0.01%	2217
2022 Q2	$11.3K	Buy	+129	New	+$15.8K	﹤0.01%	2289

Other funds holding RBOT

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

MAMHA

MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return

DDD Partners Bellevue, Washington $1.6B AUM 17.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HVCM

Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s RBOT Position: Q3 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Vicarious Surgical (RBOT) in Q3 2023, closing a stake of 115 shares — an estimated $6.32K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RBOT in Q2 2022 and held it in 5 quarters. The position peaked at $12.9K in Q3 2022. 83 funds tracked by Wall St. Rank hold RBOT as of Q3 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining Vicarious Surgical position as of Q3 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 115 Vicarious Surgical shares in Q3 2023, an estimated $6.32K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Vicarious Surgical in Q2 2022 and held it in 5 quarters.
Metropolitan Life Insurance Company (MetLife)'s Vicarious Surgical position peaked at $12.9K in Q3 2022.
83 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.